Age-related Differences in Response to Pituitary Stimulation Tests
NCT04572139 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2025-07-16
Summary
The purpose of this study to age-related differences to the response of a combined pituitary stimulation test with TRH, LHRH and ACTH.
Conditions
- Pituitary
- Aging
Interventions
- DIAGNOSTIC_TEST
-
Pituitary stimulation test
Pituitary stimulation with 0.1 mg LHRH, 0.2 mg TRH and 0.25 mg ACTH
Sponsors & Collaborators
-
Aalborg University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-23
- Primary Completion
- 2022-12-31
- Completion
- 2024-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle
NCT03878992 ·Status: UNKNOWN ·Phase: NA
-
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
NCT00097513 ·Status: COMPLETED
-
Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency
NCT02558829 ·Status: COMPLETED ·Phase: PHASE3
-
Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)
NCT03435627 ·Status: COMPLETED
-
The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis
NCT01282164 ·Status: COMPLETED ·Phase: NA
-
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
NCT00324064 ·Status: COMPLETED ·Phase: NA
-
Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.
NCT00448747 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004332 ·Status: COMPLETED
-
Seoul National University Pituitary Disease Cohort Study
NCT03474601 ·Status: UNKNOWN
-
The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin
NCT01209416 ·Status: COMPLETED ·Phase: NA
-
Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor
NCT03807076 ·Status: COMPLETED ·Phase: NA
-
Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients
NCT01562834 ·Status: COMPLETED ·Phase: PHASE4
-
Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes
NCT05206149 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
NCT03972345 ·Status: ENROLLING_BY_INVITATION
-
Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
NCT00837863 ·Status: UNKNOWN ·Phase: PHASE2
-
Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone
NCT01327924 ·Status: COMPLETED
-
Observational Prospective Study on Patients Treated With Norditropin®
NCT00960128 ·Status: COMPLETED
-
Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency
NCT01804413 ·Status: UNKNOWN ·Phase: NA
-
Impact of GH Measurements on GHD Diagnosis
NCT04508673 ·Status: COMPLETED
-
Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx®
NCT01034202 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Spectrometry Based Cutoffs for Cortisol After Stimulation Tests
NCT02818660 ·Status: COMPLETED ·Phase: NA
-
Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome
NCT00372125 ·Status: COMPLETED ·Phase: NA
-
A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency
NCT00455884 ·Status: COMPLETED
-
Metabolic Studies- Interactions Between GH and Insulin in GHDA
NCT00568568 ·Status: COMPLETED ·Phase: NA
-
A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin
NCT01435629 ·Status: COMPLETED